4//SEC Filing
HISTOGENICS CORP 4
Accession 0000899243-16-034985
$OCGNCIK 0001372299operating
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 5:01 PM ET
Size
8.2 KB
Accession
0000899243-16-034985
Insider Transaction Report
Form 4
HISTOGENICS CORPHSGX
Lewis Michael
Director
Transactions
- Conversion
Common Stock
2016-12-02+996,779→ 3,072,110 total(indirect: See Footnote) - Conversion
Series A Convertible Preferred Stock
2016-12-02−2,242.753→ 0 total(indirect: See Footnote)→ Common Stock (996,779 underlying)
Footnotes (2)
- [F1]All outstanding shares of the Issuer's Series A Convertible Preferred Stock converted on a 1:444.444444 basis into shares of the Issuer's Common Stock. These shares have no expiration date.
- [F2]The reportable securities are owned by Wilmslow Estates Limited. The Reporting Person has no beneficial interest in the trust which ultimately owns the economic interest in Wilmslow Estates Limited, but other members of the Reporting Person's family are discretionary beneficiaries in such trust. To the extent the Reporting Person may be deemed to hold an indirect beneficial interest under applicable United States securities laws, the Reporting Person disclaims such beneficial interest. The Reporting Person disclaims beneficial ownership of these shares and this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
HISTOGENICS CORP
CIK 0001372299
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001372299
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 5:01 PM ET
- Size
- 8.2 KB